Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 18;58(47):16780-16784.
doi: 10.1002/anie.201906602. Epub 2019 Aug 19.

Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals

Affiliations

Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals

Peter R Spackman et al. Angew Chem Int Ed Engl. .

Abstract

Most structure-based drug discovery methods utilize crystal structures of receptor proteins. Crystal engineering, on the other hand, utilizes the wealth of chemical information inherent in small-molecule crystal structures in the Cambridge Structural Database (CSD). We show that the interaction surfaces and shapes of molecules in experimentally determined small-molecule crystal structures can serve as effective tools in drug discovery. Our description of the shape and interaction propensities of molecules in their crystal structures can be used to screen them for specific binding compatibility with protein targets, as demonstrated through the high-throughput profiling of around 138 000 small-molecule structures in the CSD and a series of drug-protein crystal structures. Electron-density-based intermolecular boundary surfaces in small-molecule crystal structures and in target-protein pockets are utilized to identify potential ligand molecules from the CSD based on 3D shape and intermolecular interaction matching.

Keywords: crystal engineering; drug discovery; molecular recognition; noncovalent interactions; virtual screening.

PubMed Disclaimer

Similar articles

Cited by

References

    1. E. Fischer, Ber. Dtsch. Chem. Ges. 1894, 27, 2985-2993.
    1. A. Lavecchia, C. Di Giovanni, Curr. Med. Chem. 2013, 20, 2839-2860.
    1. None
    1. A. Nicholls, G. B. McGaughey, R. P. Sheridan, A. C. Good, G. Warren, M. Mathieu, S. W. Muchmore, S. P. Brown, J. A. Grant, J. A. Haigh, N. Nevins, A. N. Jain, B. Kelley, J. Med. Chem. 2010, 53, 3862-3886;
    1. G. M. Sastry, S. L. Dixon, W. Sherman, J. Chem. Inf. Model. 2011, 51, 2455-2466;

Publication types

LinkOut - more resources